Vnitr Lek 2021, 67(3):e33-e34 | DOI: 10.36290/vnl.2021.049
Komentář k článku: Co může internista udělat pro svého pacienta po ischemické cévní mozkové příhodě Vnitř Lek 2021; 67(1): 7-14
Co může diabetolog udělat pro svého pacienta po iCMP?
- 1 Interní klinika FN Motol a 2. LF UK, Praha
- 2 Interní klinika 3. LF UK a FNKV, Praha
Published: May 26, 2021 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Co může diabetolog udělat pro svého pacienta po iCMP? Vnitr Lek. 2021;67(3):e33-34. doi: 10.36290/vnl.2021.049.
References
- Škorňa M. Co může internista udělat pro svého pacienta po iCMP? Vnitr Lek 2021; 67(1): 7-14.
Go to original source...
Go to PubMed...
- Emerging Risk Factors Collaboration: Sarwar N, Gao P, Seshasai SR et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222.
Go to original source...
Go to PubMed...
- Khoury JC, Kleindorfer D, Alwell K et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013; 44(6): 1500-1504.
Go to original source...
Go to PubMed...
- Reeves MJ, Vaidya RS, Fonarow GC, Liang L, Smith EE, Matulonis R, Olson DM, Schwamm LH; Get With The Guidelines Steering Committee and Hospitals: Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke. Stroke 2010; 41: e409-e417.
Go to original source...
Go to PubMed...
- Newman GC, Bang H, Hussain SI, Toole JF: Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology 2007; 69: 2054-2062.
Go to original source...
Go to PubMed...
- Kernan WN, Viscoli CM, Furie KL et al.; IRIS Trial Investigators: Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med; 374: 1321-1331.
Go to original source...
Go to PubMed...
- Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
Go to original source...
Go to PubMed...
- Diabetes and Stroke. In: Cowie CC, Casagrande SS, Menke A, et al., Diabetes in America. Bethesda, 2018, 3rd edition.
- Doporučení pro diagnostiku a léčbu arteriální hypertenze České společnosti pro hypertenzi 2017. [cit. 2021-04-03]. Dostupné z WWW: http://www.hypertension.cz/sqlcache/widimsky-1-hypertenze-kv-prevence-2018.pdf.
- Česká společnost pro aterosklerózu. Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. [cit. 2021-04-03]. Dostupné z WWW: https://www.cskb.cz/wp-content/uploads/2019/12/Stanovisko-v%C3%BDboru-%C4%8Cesk%C3%A9-spole%C4%8Dnosti-pro-ateroskler%C3%B3zu-k-doporu%C4%8Den%C3%ADm-ESC_EAS-pro-diagnostiku-a-l%C3%A9%C4%8Dbu-dyslipidemi%C3%AD-z-roku-2019.pdf
- Task Force Members. 2019 European Society of Cardiology guidelines on diabetes, pre-diabetes,and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2020; 41, 255323.
- David S.H. Bell, Edison Goncalves. Stroke in the patient with diabetes (Part 2) - Prevention and the effects of glucose lowering therapies. Diabetes Research and Clinical Practice 2020; 164,108199.
Go to original source...
Go to PubMed...